DALLAS & FORTH WORTH, Texas—bionorthTX President and CEO, Harold Strong announced that Opus Biotech Communications (www.opusbiotech.com) will be the organization’s preferred PR/IR provider. Under this new partnership bionorthTX members are now eligible to receive discounted rates for all the communications and investor relations services the firm offers to emerging and established life sciences companies. “This program compliments other discount programs offered by bionorthTX as a member benefit,” Strong added.

“Start-up companies are focused on advancing their research,” said Opus Biotech cofounder Dan Eramian, “but unless they can compellingly articulate the value of their unique stories to investors early on, they risk leaving their technology in the lab.”

“Start-up companies are focused on advancing their research,” said Opus Biotech cofounder Dan Eramian, “but unless they can compellingly articulate the value of their unique stories to investors early on, they risk leaving their technology in the lab.”

“Emerging life sciences companies live in a highly competitive environment,” added Opus cofounder Charles Craig. “They must prove now not only that their science works, but also convince a price sensitive health care system to adopt it.”

Eramian served as the first vice president of communications for the Biotechnology Industry Organization (BIO) during the industry’s transformation from fascinating science to global health care innovator. He has managed challenging communications and investor relations at public and private biotech companies and served on their management boards.

Craig has been on the front lines of the biotech revolution as president of Georgia Bio and as a writer, editor and communicator for the Biotechnology Industry Organization (BIO), Bio World Today and annual Ernst & Young Global Biotechnology Report. During his 30-year career, he also worked as a writer and editor for mainstream newspapers, magazines, and television news.

“The principals at Opus Biotech Communications have more than four decades of experience in biotechnology communications, investor relations, government affairs and value building. bionorthTX has been very pleased with the quality of services they have provided the organization in raising awareness of our accomplishments,” said Kay Tieman, Co-Founder and Board Member of bionorthTX. “I have worked with the principals at Opus Biotech for many years in the past. They are one of the most experienced PR teams in the life science industry. They understand emerging companies and can help our members communicate the value of their technology to many audiences especially the investor community.”

About Opus Biotech Communications Services
Opus Biotech Communications works with emerging life sciences companies to tell their stories of innovation, perseverance and value at affordable rates. We create strategies for connecting with news media, investors, business partners, opinion leaders, government officials, and patient groups. Our expertise is grounded in the ability to develop clear, concise and compelling copy and messages informed by extensive experience providing strategic planning in public and investor relations, development of CEO and company reputation management programs; support for government affairs; and bioethics consultation on organizational, research, marketing and clinical care issues.

To learn more about Opus please visit our website: http://opusbiotech.com/.

For information on discounts available to members of bionorthTX, contact Dan Eramian: danieleramian@comcast.net 425-306-8716 or Charles Craig: charles.s.craig@gmail.com 404-245-0591

About bionorthTX
bionorthTX is an independent, non-profit 501(c) (6), member-driven trade association serving and representing the life science industry in North Texas. North Texas is home to 1,000 life science and medical technology related companies, six major universities and more than 26,000 industry professionals. For information on membership in bionorthTX and upcoming events visit www.bionorthtx.org.